Perkins Coie lawyers were mentioned in “DEA Erred In Rejecting Psilocybin Therapy, 9th Circ. Hears,” an article Law360,* regarding a doctor who is urging the U.S. Court of Appeals for the Ninth Circuit to find that the U.S. Drug Enforcement Administration (DEA) erred when it stated that psilocybin, the psychedelic compound produced by certain mushrooms, has no medical value.

In an opening brief filed Feb. 13, Dr. Sunil Aggarwal said the DEA ignored his arguments in favor of rescheduling psilocybin and violated the law by not consulting the U.S. Food and Drug Administration to assess psilocybin's potential uses, adding that the DEA's assessment process was fatally flawed.

Aggarwal is represented by Kathryn L. Tucker of the National Psychedelics Association, Matthew C. Zorn and Austin T. Brumbaugh of Yetter Coleman LLP, Shane Pennington of Vicente Sederberg LLP, and James F. Williams, Thomas J. Tobin, Andrew J. Kline, Holly Martinez, and Caleb Bacos of Perkins Coie LLP.

Read the full article in Law360.*

*Subscription-based publication